Atrium Mortgage Investment Corporation Announces the Appointment of New CFO
Toronto, Ontario--(Newsfile Corp. - June 2, 2025) - Atrium Mortgage Investment Corporation (TSX: AI) ("Atrium") today announced the appointment of Gigi Wong as Chief Financial Officer, effective June 2, 2025.
Robert Goodall, CEO of Atrium, stated, "We are very pleased to welcome Gigi to Atrium. She brings more than two decades of experience in finance and operational leadership, and will be responsible for overseeing the company's financial reporting and compliance functions. Gigi has held senior financial leadership roles across the asset management and financial services sectors. Her experience spans finance operations, risk management, and leading teams through periods of growth and change. She is recognized for her disciplined approach to financial governance and her ability to align financial strategies with broader business objectives. As both a Chartered Professional Accountant (CPA) and Chartered Financial Analyst (CFA), Gigi's credentials and leadership track record make her a great asset to our executive team. We are excited to have her on board. I also want to sincerely thank Razvan Vulcu who has acted as our Interim CFO over the last couple months and consistently performed at a very high level."
About Atrium
Canada's Premier Non-Bank Lender™
Atrium is a non-bank provider of residential and commercial mortgages that lends in major urban centres in Canada where the stability and liquidity of real estate are high. Atrium's objectives are to provide its shareholders with stable and secure dividends and preserve shareholders' equity by lending within conservative risk parameters.
Atrium is a Mortgage Investment Corporation (MIC) as defined in the Canada Income Tax Act, so is not taxed on income provided that its taxable income is paid to its shareholders in the form of dividends within 90 days after December 31 each year. Such dividends are generally treated by shareholders as interest income, so that each shareholder is in the same position as if the mortgage investments made by the company had been made directly by the shareholder. For further information, please refer to regulatory filings available at www.sedarplus.ca or Atrium's website at www.atriummic.com.
For further information, please contact
Robert G. Goodall Chief Executive Officer
Gigi WongChief Financial Officer
(416) 867-1053info@atriummic.com www.atriummic.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/254238
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
Lifordi Immunotherapeutics Presents Preclinical Data on Glucocorticoid Antibody Drug Conjugate LFD-200 to Treat Autoimmune and Inflammatory Diseases at EULAR 2025
Burlington, Massachusetts--(Newsfile Corp. - June 11, 2025) - Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, presented preclinical data on its lead program for LFD-200, an ADC delivering a potent glucocorticoid (GC) directly to immune cells. Results of multiple in vitro and in vivo studies in mice and in non-human primates (NHPs) demonstrated that LFD-200 achieves targeted and sustained delivery of its GC payload to immune cells, resulting in efficacy without systemic toxicity. These data were presented at the European Alliance of Associations for Rheumatology (EULAR) meeting in Barcelona. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. About Lifordi Lifordi Immunotherapeutics, Inc. is leading the way in leveraging the success of antibody-drug conjugates (ADCs) to develop treatments for autoimmune and inflammatory disorders. The Company's lead ADC, LFD-200, has demonstrated efficacy in multiple preclinical disease models by targeting myeloid and lymphoid cells using a highly internalized cell surface membrane protein (VISTA). Lifordi has also applied its novel drug delivery platform to other diverse payloads, such as small molecules, antisense oligonucleotides (ASOs) and siRNA. As experienced drug developers in immunology and inflammatory diseases, together with expert clinical advisors, a strong partnering track record, and funding from ARCH Venture Partners, 5AM Ventures, and Atlas Venture to support initial clinical data, Lifordi is committed to changing how immune and inflammatory diseases are treated. For more information, please visit Contacts: Theresa McNeely tmcneely@ Source: Lifordi To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Hamilton Spectator
an hour ago
- Hamilton Spectator
DIRTT Announces Approval to Trade on the OTCQX® Best Market
CALGARY, Alberta, June 11, 2025 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. ('DIRTT' or the 'Company') (TSX: DRT; OTC: DRTTF), a leader in industrialized construction, announced today that it has been approved to trade on the OTCQX® Best Market. It will begin trading today on OTCQX under the symbol 'DRTTF.' The Company upgraded to OTCQX from the Pink® market. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . 'DIRTT's presence on the OTCQX Market enhances the marketability of our securities and strengthens our appeal to U.S. based institutional investors, wealth advisors, and individual investors,' said Benjamin Urban, CEO of DIRTT. 'The increased exposure and visibility from trading on the OTCQX Market typically benefits companies like ours with the potential for additional trading volume and more liquidity.' DIRTT will continue to trade in its home market on the Toronto Stock Exchange under the symbol 'DRT.' About DIRTT Environmental Solutions Ltd DIRTT is a leader in industrialized construction. DIRTT's system of physical products and digital tools empowers organizations, together with construction and design leaders, to build high-performing, adaptable, interior environments. Operating in the workplace, healthcare, education, and public sector markets, DIRTT's system provides total design freedom, and greater certainty in cost, schedule, and outcomes. DIRTT's interior construction solutions are designed to be highly flexible and adaptable, enabling organizations to easily reconfigure their spaces as their needs evolve. FOR MORE INFORMATION, PLEASE CONTACT: DIRTT Investor Relations: ir@
Yahoo
an hour ago
- Yahoo
DAVIDsTEA Announces Date of First Quarter Fiscal 2025 Earnings
MONTREAL, June 11, 2025 (GLOBE NEWSWIRE) -- DAVIDsTEA Inc. (TSX-Venture: DTEA) ('DAVIDsTEA' or the 'Company'), a leading tea merchant in North America, announced today that its financial results for the first quarter of Fiscal 2025 will be released before markets open on June 17, 2025. The Company will host a webcast same day at 8:30 a.m. Eastern Time to discuss the financial results. Details of the webcast Via the internet at: in the "investor" section, or at: An online archive of the webcast will be available within two hours of the conclusion of the call and will remain available for 30 days. About DAVIDsTEADAVIDsTEA offers a specialty branded selection of high-quality proprietary loose-leaf teas, pre-packaged teas, tea sachets, tea-related accessories and gifts through its e-commerce platform at and the Amazon Marketplace, its wholesale customers which include over 4,000 grocery stores and pharmacies, over 1,500 convenience stores in Canada and over 900 grocery stores in the United States, as well as 20 company-owned stores across Canada. The Company offers primarily proprietary tea blends that are exclusive to the Company, as well as traditional single-origin teas and herbs. The team's passion for and knowledge of tea permeates the Company's culture and is rooted in an excitement to explore the taste, health and lifestyle elements of tea. With a focus on innovative flavours, wellness-driven ingredients and organic tea, the Company launches seasonally driven 'collections' with a mission of making tea fun and accessible to all. The Company is headquartered in Montréal, Canada. Contact Information MBC Capital Markets AdvisorsPierre Boucherpierre@ 514-731-0000 DAVIDsTEA Investor Relationsinvestors@
